Copyright
©2012 Baishideng Publishing Group Co., Limited. All rights reserved.
World J Gastroenterol. Sep 28, 2012; 18(36): 5058-5064
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5058
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5058
Crohn’s disease genotypes of patients in remission vs relapses after infliximab discontinuation
Cathy Lu, Alistair Waugh, Levinus A Dieleman, Karen I Kroeker, Christopher W Teshima, Karen Wong, Richard N Fedorak, Division of Gastroenterology, Zeidler Ledcor Center, University of Alberta, Edmonton, AB T6G 2X8, Canada
Robert J Bailey, Leah Gramlich, Kata Matic, Daniel Sadowski, Dennis Todoruk, Clarence Wong, Division of Gastroenterology, Royal Alexandra Hospital, Edmonton, AB T5H 3V9, Canada
Raeleen Cherry, Division of Gastroenterology, Grey Nuns Hospital, Edmonton, AB T6L 5X8, Canada
Mario Millan, Division of Gastroenterology, Misericordia Hospital, Edmonton, AB T5R 4H5, Canada
Author contributions: Lu C collected and analyzed data and drafted manuscript; Waugh A contributed to the collection of the data; Bailey RJ, Cherry R, Dieleman LA, Gramlich L, Matic K, Millan M, Kroeker KI, Sadowski D, Teshima CW, Todoruk D, Wong C and Wong K contributed to revision of manuscript; Fedorak RN contributed by developing study concept and design, interpretation of data, and critical revision of manuscript.
Supported by Center of Excellence for Gastrointestinal, Inflammation and Immunity Research at the University of Alberta
Correspondence to: Richard N Fedorak, MD, Division of Gastroenterology, Zeidler Ledcor Center, University of Alberta, Edmonton, AB T6G 2X8, Canada. richard.fedorak@ualberta.ca
Telephone: +1-780-4926941 Fax: +1-780-4928121
Received: February 19, 2012
Revised: May 31, 2012
Accepted: June 8, 2012
Published online: September 28, 2012
Revised: May 31, 2012
Accepted: June 8, 2012
Published online: September 28, 2012
Core Tip